Edgerton S - Search Results

1

HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.

Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA. Benz CC, et al. Among authors: edgerton s. Oncogene. 1997 Sep 25;15(13):1513-25. doi: 10.1038/sj.onc.1201331. Oncogene. 1997. PMID: 9380403

2

pS2 expression and response to hormonal therapy in patients with advanced breast cancer.

Schwartz LH, Koerner FC, Edgerton SM, Sawicka JM, Rio MC, Bellocq JP, Chambon P, Thor AD. Schwartz LH, et al. Among authors: edgerton sm. Cancer Res. 1991 Jan 15;51(2):624-8. Cancer Res. 1991. PMID: 1985778

3

Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit.

Lloveras B, Edgerton S, Thor AD. Lloveras B, et al. Among authors: edgerton s. Am J Clin Pathol. 1991 Jan;95(1):41-7. doi: 10.1093/ajcp/95.1.41. Am J Clin Pathol. 1991. PMID: 1987751

4

Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations.

Thor A, Benz C, Moore D 2nd, Goldman E, Edgerton S, Landry J, Schwartz L, Mayall B, Hickey E, Weber LA. Thor A, et al. Among authors: edgerton s. J Natl Cancer Inst. 1991 Feb 6;83(3):170-8. doi: 10.1093/jnci/83.3.170. J Natl Cancer Inst. 1991. PMID: 1988702

5

Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.

Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ, et al. Thor AD, et al. Among authors: edgerton sm. Cancer Res. 1989 Dec 15;49(24 Pt 1):7147-52. Cancer Res. 1989. PMID: 2573426

6

Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications.

Thor AD, Edgerton SM. Thor AD, et al. Among authors: edgerton sm. Semin Nucl Med. 1989 Oct;19(4):295-308. doi: 10.1016/s0001-2998(89)80022-4. Semin Nucl Med. 1989. PMID: 2678481 Review.

7

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

Axelsson K, Ljung BM, Moore DH 2nd, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH. Axelsson K, et al. Among authors: edgerton sm. J Natl Cancer Inst. 1995 Jul 5;87(13):997-1008. doi: 10.1093/jnci/87.13.997. J Natl Cancer Inst. 1995. PMID: 7543156

8

p53 mutations in benign breast tissue.

Millikan R, Hulka B, Thor A, Zhang Y, Edgerton S, Zhang X, Pei H, He M, Wold L, Melton LJ, et al. Millikan R, et al. Among authors: edgerton s. J Clin Oncol. 1995 Sep;13(9):2293-300. doi: 10.1200/JCO.1995.13.9.2293. J Clin Oncol. 1995. PMID: 7666086

9

Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay.

Eng Tan P, Benz CC, Dollbaum C, Moore DH 2nd, Edgerton SM, Zava DT, Thor AD. Eng Tan P, et al. Among authors: edgerton sm. Ann Oncol. 1994 Apr;5(4):329-36. doi: 10.1093/oxfordjournals.annonc.a058836. Ann Oncol. 1994. PMID: 8075029 Free article.

10

p53 gene mutations and protein accumulation in human ovarian cancer.

Kupryjańczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW. Kupryjańczyk J, et al. Among authors: edgerton sm. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4961-5. doi: 10.1073/pnas.90.11.4961. Proc Natl Acad Sci U S A. 1993. PMID: 8506342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page